Spruce Biosciences Says On March 16, Entered Termination Agreement With Kaken Pharmaceutical; Collaboration Agreement With Kaken Pharmaceutical To Terminate Effective March 31, 2026; All Licenses & Rights Granted By Co To Kaken To Be Terminated; No Unearned Milestone Payments Or Royalties